🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)My year on Mounjaro — July 2024 Page 4

My year on Mounjaro — July 2024

oliver_london Sat, Sep 21, 2024 at 12:11 PM 48 replies 2,414 viewsPage 4 of 10
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Sep 21, 2024 at 5:51 PM#16

Just wanted to say — for anyone reading this My year on Mounjaro thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

20 8NeuroNate, JessicaH_TX, KevinCompounds and 17 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Sep 21, 2024 at 6:08 PM#17

oliver_london's experience with My year on Mounjaro July resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 54 lbs in 9 months.

One thing I would add that oliver_london did not mention: the mental health improvements were just as significant.

Last edited: Sep 21, 2024 at 8:08 PM
23 14SleepFixSam, PurityPaulOR, MaxMetOK and 20 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Sep 21, 2024 at 6:25 PM#18

Saving this for reference. Top-tier content.

19 3greg_boulder, quinn_sf, NurseLeah_Nash and 16 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Sep 21, 2024 at 6:42 PM#19

As a pharmacist, I want to add some clinical context to this discussion on My year on Mounjaro July 2024.

Building on what oliver_london said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Sep 21, 2024 at 9:42 PM
39 24LabKate, kate.chem, DataDave and 36 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Sep 21, 2024 at 6:59 PM#20

Subscribing to this thread. My year on Mounjaro July is exactly what I've been researching. 🙏

9 3SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 6 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register